Collier Kathryn J - Insider Non-Derivative Transactions at Regulus Therapeutics Inc. (RGLS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 25, 2024, Collier Kathryn J's relationship to Regulus Therapeutics Inc. (RGLS) is Director, and currently has 6,740 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RGLS insiders.
Data Source: SEC.
Collier Kathryn J - Insider Non-Derivative Transactions at RGLS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 26, 2024 | P -- (Common Stock) | 4000 | 1.82 | 6740 |